MMP9 and brain ischemia: Minocycline, a semi-synthetic tetracycline with anti-inflammatory and anti-apoptotic properties, inhibits MMP-9 activity and has shown neuroprotection in cerebral ischemia and in other models of brain injury [87,89,90].